Madison Mills / Axios: OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind — OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug…
Back to Technology
Technology
October 20, 2026 at 6:20 PM
OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)
Techmeme
Excerpt from Techmeme.